Clinical Trial

Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer

Study acronym: STEREOLIVER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Intervention research involving the human person, phase II, prospective, multicentric, non-randomized and multi-cohort study. The eligibility criteria are broad, on purpose, so every patient, able to be treated by SBRT and unable to participate in another trial (non eligible patient or non included centers), can be included in this national study, in a prospective way.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2018-01-23; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2023-12-13
Status change: Not Yet Recruiting → Recruiting 2019-03-15
Trial Details
NCT Number NCT03408665
Lead Sponsor Centre Oscar Lambret
Collaborators: Canceropôle Nord Ouest
Conditions Liver Cancer, Liver Metastases
Enrollment 280 participants
Start Date 2019-03-13
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-30